Scientists have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor. Each is a potential therapeutic target to stop cancer recurrence, and one -- MUC1 -- is already in clinical trials.
Read more https://www.sciencedaily.com/releases/2024/11/241106142736.htm